Citadel Advisors »

Candel Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Candel Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Candel Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Candel Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $25k 17k 1.47
2023-09-30 $30k 32k 0.93
2023-03-31 $65k 47k 1.37

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Candel Therapeutics

Northpond Ventures
Sands Capital Ventures
Vanguard Group
Geode Capital Management
Bridgeway Capital Management
Baystate Wealth Management
BlackRock
Mariner Wealth Advisors
Resources Investment Advisors
Northern Trust
Commonwealth Equity Services
Two Sigma Investments
Tower Research Capital
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Candel Therapeutics